Re: Exempt Distribution Jan 20

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

ryau1135

Rank: Mail Room [?]

Points: 56 [?]

Votes: 3 Score: 4.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Exempt Distribution Jan 20

in response to

Re: Exempt Distribution Jan 20

Telepanel

posted on Jan 30, 2021 12:30PM

I think someone mentioned it was the availability of shares. There might be enough shares available on the OTC vs a PP.

FWIW, I bought 1,000 shares on the OTC and it merged it with my original RVX newco shares. I know someone else said the same but just wanted to add the same happened for me.

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply